Lander Egaña-Gorroño
Impact in
- Clinical Biochemistry top 5%
- Advanced Glycation End Products research
- Virology top 10%
- HIV Research and Treatment
Papers in
- Virology 7
- HIV Research and Treatment 7
-
- RNA Interference and Gene Delivery 2
- Co-authors
- Ann Marie Schmidt (5 shared papers)Alexander Shekhtman (4 shared papers)Raquel López‐Díez (4 shared papers)Ravichandran Ramasamy (4 shared papers)Sergey Reverdatto (2 shared papers)Paul F. Gugger (2 shared papers)Gautham Yepuri (1 shared paper)Tuixent Escribà (8 shared papers)
- Journals
- PLoS ONE (2 papers)Scientific Reports (1 paper)Frontiers in Immunology (1 paper)Cardiovascular Research (1 paper)Atherosclerosis (1 paper)
- Partner nations
- United StatesSpainAustralia
In The Last Decade
Lander Egaña-Gorroño
17 papers receiving 447 citations
Peers
Comparison fields: 5 of 80
- Clinical Biochemistry 143
- Virology 72
- Endocrinology, Diabetes and Metabolism 89
- Emergency Medicine 50
- Cancer Research 63
Countries citing papers authored by Lander Egaña-Gorroño
This map shows the geographic impact of Lander Egaña-Gorroño's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lander Egaña-Gorroño with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lander Egaña-Gorroño more than expected).
Fields of papers citing papers by Lander Egaña-Gorroño
This network shows the impact of papers produced by Lander Egaña-Gorroño. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lander Egaña-Gorroño. The network helps show where Lander Egaña-Gorroño may publish in the future.
Co-authors
The 25 scholars most cited alongside Lander Egaña-Gorroño, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 151 | |
| 2 | 2021 | 54 | |
| 3 | 2014 | 46 | |
| 4 | 2020 | 45 | |
| 5 | 2012 | 27 | |
| 6 | 2019 | 22 | |
| 7 | 2016 | 19 | |
| 8 | 2017 | 17 | |
| 9 | 2021 | 14 | |
| 10 | 2021 | 13 | |
| 11 | 2018 | 12 | |
| 12 | 2020 | 10 | |
| 13 | 2014 | 9 | |
| 14 | 2021 | 7 | |
| 15 | 2016 | 7 | |
| 16 | 2014 | 3 | |
| 17 | 2012 | 2 |
About Lander Egaña-Gorroño
Lander Egaña-Gorroño is a scholar working on Virology, Molecular Biology, Emergency Medicine, Clinical Biochemistry and Endocrinology, Diabetes and Metabolism, having authored 17 papers that have together received 458 indexed citations. Recurring topics across this work include HIV Research and Treatment (7 papers), HIV-related health complications and treatments (5 papers), Advanced Glycation End Products research (4 papers), MicroRNA in disease regulation (3 papers), Diabetes and associated disorders (3 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (2 papers), Atherosclerosis and Cardiovascular Diseases (2 papers) and RNA Interference and Gene Delivery (2 papers). The work is most often cited by research in Clinical Biochemistry (143 citations), Virology (72 citations), Endocrinology, Diabetes and Metabolism (89 citations), Emergency Medicine (50 citations) and Cancer Research (63 citations). Lander Egaña-Gorroño has collaborated with scholars based in United States, Spain and Australia. Frequent co-authors include Ann Marie Schmidt, Alexander Shekhtman, Raquel López‐Díez, Ravichandran Ramasamy, Sergey Reverdatto, Paul F. Gugger, Gautham Yepuri, Tuixent Escribà, Mireia Arnedo and Estebán Martínez. Their work appears in journals such as PLoS ONE, Scientific Reports, Frontiers in Immunology, Cardiovascular Research and Atherosclerosis.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.